BPG is committed to discovery and dissemination of knowledge
Original Article
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 21, 2009; 15(27): 3367-3375
Published online Jul 21, 2009. doi: 10.3748/wjg.15.3367
Table 1 Grouping by MRI findings
Category 1Category 2Category 3Category 4
Mucosal enhancementNilMildMildMild or marked
Transmural enhancementNilNil or mildNil or mildMarked
Wall thickness (mm)> 3< 6> 6> 3
Table 2 Characteristics of the CD patients prior to the MRI examination
CD (n = 52)
Gender: male38.5% (20/52)
Age at diagnosis (yr)38.9 ± 16.0 (14-79)
A1 ≤ 1611.5% (6/52)
A2 17-4055.8% (29/52)
A3 > 4032.7% (17/52)
Crohn’s disease
L1 Terminal ileum78.8% (41/52)
L2 Colon0% (0/52)
L3 Ileocolonic19.2% (10/52)
L4 Upper GI7.7% (4/52)
P Perianal9.6% (5/52)
B1 Non-stricturing
Non-penetrating75.0% (39/52)
B2 Stricturing19.2% (10/52)
B3 Penetrating5.8% (3/52)
Colectomy11.5% (6/52)
Terminal ileal resection25.0% (13/52)
Proximal SB resection1.9% (1/52)
Table 3 MRI findings of patients according to the MRI category
MRI group (n)Male (%)Age (yr)Bowel length involved (cm)Wall thickness (mm)Degree of SB wall enhancementMucosal enhancement (%)Transmural enhancement (%)Mesenterichyperaemia (%)Fibrofatty proliferation (%)Regional lymph nodes (%)Free fluid (%)Narrowed lumen no hold-up (%)Prestenotic dilation ± holdup (%)Fistula (%)
1 (7)28.637.9 ± 9.46.3 ± 7.9< 3 0%None 100%00014.3014.357.114.30
(23-54)(1-25)3-6 71.4%Mild 0%
> 6 28.6%Marked 0%
2 (9)22.232.8 ± 9.213.8 ±12.3< 3 11.1%None 0%10088.933.333.366.633.344.4022.2
(17-78)(3-30)3-6 88.9%Mild 100%
> 6 0%Marked 0%
3 (16)43.840.1 ± 16.216.2 ± 12.0< 3 0%None 0%93.843.850.062.537.518.818.862.525.0
(14-79)(2-50)3-6 0%Mild 100%
> 6 100%Marked 0%
4 (20)45.041 ± 19.219.2 ± 11.6< 3 0%None 0%10090.075.075.085.035.035.035.020.0
(14-49)(2-45)3-6 10%Mild 0%
> 6 90%Marked 100%
Table 4 MRI category, medical therapy and clinical response (%)
MRI groupSteroids5ASAAntibioticsAZA/6MPMTXAnti-TNF αResponse
1 (n = 7)57.1057.1028.5085.700.0042.9014.30
2 (n = 9)55.5088.900.0022.2033.3044.40100.00
3 (n = 16)81.3068.806.3050.000.0012.5043.80
4 (n = 20)70.0070.005.0040.000.0035.0050.00
Responders (n = 27)63.0063.0011.1044.403.7025.90N/A
Non-responders (n = 25)76.0080.004.0048.008.0036.00N/A
Table 5 MRI category, response to medical therapy in relation to luminal narrowing with and without hold up
MRI groupNo narrowed lumenNarrowed lumen no hold upNarrowed lumen with hold up
1Response 0% (0/2)Response 25% (1/4)Response 0% (0/1)
n = 7No response 100% (2/2)No response 75% (3/4)No response 100% (1/1)
2Response 100% (5/5)Response 100% (4/4)Response N/A
n = 9No response 0% (0/5)No response 0% (0/4)No response N/A
3Response 66.7% (2/3)Response 66.7% (2/3)Response 40% (4/10)
n = 16No response 33.3% (1/3)No response 33.3% (1/3)No response 60% (6/10)
4Response 83.3% (5/6)Response 57.1% (4/7)Response 14.3% (1/7)
n = 20No response 16.7% (1/6)No response 42.9% (3/7)No response 85.7% (6/7)
TotalResponse 75.0% (12/16)Response 61.1% (11/18)Response 27.8% (5/18)
n = 52No response 25.0% (4/16)No response 38.9% (7/18)No response 72.2% (7/18)
Table 6 Correlation of MRI findings with surgical pathology
No.SexAgeMRI assessment
Surgical pathology
GroupFistulaInflammationFibrosisFistula
1F231NoMinimalYesNo
2M451NoNoYesNo
3F392YesMildNoYes
4M173NoMildYesNo
5F593NoMildYesNo
6F313NoMildYesNo
7M183NoModerateYesNo
8M243YesMildYesYes
9F373NoMildYesNo
10M413NoMildYesNo
11F624NoFloridYesNo
12M194NoFloridYesNo
13M614NoFloridYesNo
14F214YesFloridNoYes
15M434YesFloridYesYes
16M144NoFloridNoNo
17F564NoFloridNoNo


Write to the Help Desk